Medicine and Dentistry
Patient
100%
Inpatient
45%
Therapeutic Procedure
42%
Biliary Tract Cancer
37%
Neoplasm
31%
Overall Survival
29%
Chemotherapy
23%
Neuroendocrine Carcinoma
18%
Neuroendocrine Tumor
17%
Cholangiocarcinoma
16%
Surgery
15%
Diseases
14%
Systematic Review
14%
Meta-Analysis
14%
Pancreas Cancer
13%
Survival
12%
Diagnosis
12%
Analysis
11%
Progression Free Survival
11%
Malignant Neoplasm
11%
Age
11%
Clinical Trial
9%
Pancreas Adenocarcinoma
9%
Hepatocellular Carcinoma
9%
Prognostic Factor
8%
Cancer
7%
Systemic Therapy
7%
Prognosis
7%
Gemcitabine
6%
Development
6%
Lymphocyte
6%
Quality of Life
6%
Bile Duct Cancer
6%
Platinum
6%
Biological Marker
5%
Neutrophil
5%
Targeted Therapy
5%
Toxicity
5%
Retrospective Study
5%
Glioblastoma
5%
Male
5%
Pharmacology, Toxicology and Pharmaceutical Science
Biliary Tract Cancer
27%
Chemotherapy
16%
Overall Survival
16%
Neoplasm
14%
Neuroendocrine Carcinoma
12%
Gemcitabine
11%
Cisplatin
10%
Clinical Trial
8%
Survival
8%
Diseases
8%
Bile Duct Carcinoma
7%
Pancreas Cancer
7%
Malignant Neoplasm
7%
Progression Free Survival
7%
Biological Marker
7%
Liver Cell Carcinoma
6%
Etoposide
6%
Platinum
6%
Toxicity
5%
Pancreas Adenocarcinoma
5%
Nursing and Health Professions
Patient
13%
Biliary Tract Cancer
9%
Inpatient
7%
Chemotherapy
6%
Overall Survival
6%
Pancreas Cancer
5%
Neoplasm
5%